Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 46% ± 24% | |
oligodendrocyte precursor cell | 8 studies | 26% ± 10% | |
GABAergic neuron | 7 studies | 43% ± 21% | |
astrocyte | 7 studies | 32% ± 11% | |
interneuron | 6 studies | 40% ± 18% | |
ciliated cell | 5 studies | 26% ± 8% | |
endothelial cell | 4 studies | 31% ± 12% | |
cardiac muscle cell | 4 studies | 21% ± 2% | |
GABAergic interneuron | 3 studies | 23% ± 4% | |
granule cell | 3 studies | 27% ± 8% | |
neuron | 3 studies | 32% ± 9% | |
ependymal cell | 3 studies | 33% ± 14% | |
oligodendrocyte | 3 studies | 29% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 32% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 478.78 | 653 / 653 | 99% | 4.78 | 601 / 605 |
ovary | 100% | 544.55 | 180 / 180 | 99% | 5.77 | 425 / 430 |
brain | 99% | 231.10 | 2614 / 2642 | 99% | 3.84 | 699 / 705 |
breast | 100% | 349.03 | 457 / 459 | 94% | 3.42 | 1054 / 1118 |
stomach | 100% | 286.05 | 359 / 359 | 93% | 3.29 | 267 / 286 |
intestine | 100% | 297.79 | 962 / 966 | 93% | 3.04 | 492 / 527 |
prostate | 100% | 390.84 | 244 / 245 | 93% | 2.83 | 468 / 502 |
esophagus | 100% | 280.68 | 1438 / 1445 | 91% | 3.05 | 166 / 183 |
pancreas | 100% | 335.12 | 327 / 328 | 88% | 1.97 | 156 / 178 |
adrenal gland | 98% | 260.61 | 253 / 258 | 89% | 3.40 | 205 / 230 |
kidney | 100% | 332.36 | 89 / 89 | 87% | 2.72 | 782 / 901 |
lung | 95% | 268.97 | 551 / 578 | 90% | 2.76 | 1040 / 1155 |
bladder | 100% | 348.95 | 21 / 21 | 82% | 2.32 | 413 / 504 |
uterus | 100% | 534.35 | 170 / 170 | 70% | 2.07 | 322 / 459 |
skin | 100% | 301.27 | 1801 / 1809 | 63% | 1.35 | 297 / 472 |
spleen | 100% | 201.55 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 255.23 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 266.26 | 1325 / 1335 | 0% | 0 | 0 / 0 |
liver | 65% | 57.49 | 148 / 226 | 30% | 0.52 | 120 / 406 |
heart | 94% | 203.18 | 807 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 1.67 | 24 / 29 |
muscle | 73% | 70.90 | 587 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 1.75 | 31 / 45 |
eye | 0% | 0 | 0 / 0 | 39% | 0.77 | 31 / 80 |
peripheral blood | 25% | 91.94 | 231 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0006955 | Biological process | immune response |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IRAK1BP1 |
Protein name | Interleukin 1 receptor associated kinase 1 binding protein 1 Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1) |
Synonyms | |
Description | FUNCTION: Component of the IRAK1-dependent TNFRSF1A signaling pathway that leads to NF-kappa-B activation and is required for cell survival. Acts by enhancing RELA transcriptional activity (By similarity). . |
Accessions | U3KQ57 U3KQ34 Q5VVH5 U3KQ00 ENST00000369940.7 ENST00000606868.5 ENST00000607739.1 ENST00000606929.1 |